Cargando…

Use and Applicability of the Gail Model to Calculate Breast Cancer Risk: A Scoping Review

OBJECTIVE: To perform a scoping review of the applicability of the Gail model in different countries for different ethnicities. METHODS: The review was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevanato, Kely Paviani, Pedroso, Raíssa Bocchi, Dell Agnolo, Cátia Millene, Santos, Lander Dos, Pelloso, Fernando Castilho, Carvalho, Maria Dalva de Barros, Pelloso, Sandra Marisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375619/
https://www.ncbi.nlm.nih.gov/pubmed/35485666
http://dx.doi.org/10.31557/APJCP.2022.23.4.1117
Descripción
Sumario:OBJECTIVE: To perform a scoping review of the applicability of the Gail model in different countries for different ethnicities. METHODS: The review was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist and search strategies based on the PICOS approach. The reviewed articles were included if they were published between 2013 and 2018 in English, Portuguese, or Spanish; were original articles available in full online; and described the use of the Gail model. The PubMed, Embase, and Web of Science data bases were searched. RESULTS: A total of 38 articles eligible for analysis were identified, of which 16 used the Gail model to assess breast cancer risk in women, eight analyzed the applicability of this tool in their population, seven compared the tool and/or modified it according to the specific risk factors of their population, and seven cited the model in determining eligibility for chemoprevention. CONCLUSION: The Gail model has different applicabilities Greater effectiveness and breast cancer risk are found in developed countries.